Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Concomitant Hypofractionated IMRT Boost Versus Conventional Fractionated IMRT Boost for Localized High Risk Prostate Cancer

NCT03526510 is registered in ClinicalTrials.gov with Dr. Patrick Cheung as lead sponsor.

NCT NCT03526510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03526510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Concomitant Hypofractionated IMRT Boost Versus Conventional Fractionated IMRT Boost for Localized High Risk Prostate Cancer
Lead sponsor
Dr. Patrick Cheung
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2011
Completion date
December 31, 2024
Enrollment
178 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer